SEARCH

SEARCH BY CITATION

References

  • Arlen, P.A., Falconer, R., Cherukumilli, S., Cole, A., Cole, A.M., Oishi, K.K. and Daniell, H. (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J. 5, 511525.
  • Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L. and Muller, M. (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol. 77, 92119220.
  • Bock, R. and Khan, M.S. (2004) Taming plastids for a green future. Trends Biotechnol. 22, 311318.
  • Breitburd, F., Kirnbauer, R., Hubbert, N.L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J.T. and Lowy, D.R. (1995) Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69, 39593963.
  • Chebolu, S. and Daniell, H. (2007) Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol. J. 5, 230239.
  • Christensen, N.D., Dillner, J., Eklund, C., Carter, J.J., Wipf, G.C., Reed, C.A., Cladel, N.M. and Galloway, D.A. (1996) Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology, 223, 174184.
  • Crum, C., Jones, C. and Kirkpatrick, P. (2006) Quadrivalent human papillomavirus recombinant vaccine. Nat. Rev. Drug Discov. 5, 629630.
  • Daniell, H. (1997) Transformation and foreign gene expression in plants by microprojectile bombardment. Methods Mol. Biol. 62, 463489.
  • Daniell, H. (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol. J. 1, 10711079.
  • Daniell, H., Lee, S.B., Panchal, T. and Wiebe, P.O. (2001a) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 10011009.
  • Daniell, H., Streatfield, S.J. and Wycoff, K. (2001b) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6, 219226.
  • Daniell, H., Khan, M.S. and Allison, L. (2002) Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7, 8491.
  • Fernández-San Millán, A., Mingo-Castel, A., Miller, M. and Daniell, H. (2003) A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1, 7179.
  • Fernández-San Millán, A., Farran, I., Molina, A., Mingo-Castel, A.M. and Veramendi, J. (2007) Expression of recombinant proteins lacking methionine as N-terminal amino acid in plastids: human serum albumin as a case study. J. Biotechnol. 127, 593604.
  • Fleury, M.J., Touzé, A., De Sanjosé, S., Bosch, F.X., Klaustermeiyer, J. and Coursaget, P. (2008) Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expression pseudovirions. Clin. Vaccine Immunol. 15, 172175.
  • Floss, D.M., Falkenburg, D. and Conrad, U. (2007) Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 16, 315332.
  • Franceschi, S. (2005) The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res. 166, 277297.
  • Heino, P., Dillner, J. and Schwartz, S. (1995) Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Virology, 214, 349359.
  • IARC (1995) Human Papillomaviruses. Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC/WHO.
  • Kane, M.A., Sherris, J., Coursaget, P., Aguado, T. and Cutts, F. (2006) Chapter 15: HPV vaccine use in the developing world. Vaccine, 24 (Suppl. 3), S132S139.
  • Kim, S.N., Jeong, H.S., Park, S.N. and Kim, H.J. (2007) Purification and immunogenicity study of human papillomavirus type 16, L1 protein in Saccharomyces cerevisiae. J. Virol. Methods, 139, 2430.
  • Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D.R. and Schiller, J.T. (1993) Efficient self-assembly of human papillomavirus type 16, L1 and L1–L2 into virus-like particles. J. Virol. 67, 69296936.
  • Kohl, T., Hitzeroth, I.I., Stewart, D., Varsani, A., Govan, V.A., Christensen, N.D., Williamson, A.L. and Rybicki, E.P. (2006) Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study. Clin. Vaccine Immunol. 13, 845853.
  • Koutsky, L.A., Ault, K.A., Wheeler, C.M., Brown, D.R., Barr, E., Alvarez, F.B., Chiacchierini, L.M. and Jansen, K.U. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl. J. Med. 347, 16451651.
  • Koya, V., Moayeri, M., Leppla, S.H. and Daniell, H. (2005) Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun. 73, 82668274.
  • Kusnadi, A., Nikolov, Z. and Howard, J. (1997) Production of recombinant proteins in transgenic plants: practical considerations. Biotechnol. Bioeng. 56, 473484.
  • Li, M., Cripe, T.P., Estes, P.A., Lyon, M.K., Rose, R.C. and Garcea, R.L. (1997) Expression of the human papillomavirus type 11, L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J. Virol. 71, 29882995.
  • Liu, H.L., Li, W.S., Lei, T., Zheng, J., Zhang, Z., Yan, X.F., Wang, Z.Z., Wang, Y.L. and Si, L.S. (2005) Expression of human papillomavirus type 16, L1 protein in transgenic tobacco plants. Acta Biochim. Biophys. Sin. 37, 153158.
  • Maclean, J., Koekemoer, M., Olivier, A.J., Stewart, D., Hitzeroth, I.I., Rademacher, T., Fischer, R., Williamson, A.L. and Rybicki, E.P. (2007) Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J. Gen. Virol. 88, 14601469.
  • Maliga, P. (2004) Plastid transformation in higher plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 55, 289313.
  • Mayfield, S.P., Franklin, S.E. and Lerner, R.A. (2003) Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA, 100, 438442.
  • Mison, D. and Curling, J. (2000) The industrial production costs of recombinant therapeutic proteins expressed in transgenic corn. Biopharm. Int. 13, 4854.
  • Modis, Y., Trus, B.L. and Harrison, S.C. (2002) Atomic model of the papillomavirus capsid. EMBO J. 21, 47544762.
  • Molina, A., Hervas-Stubbs, S., Daniell, H., Mingo-Castel, A.M. and Veramendi, J. (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2, 141153.
  • Molina, A., Veramendi, J. and Hervas-Stubbs, S. (2005) Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology, 342, 266275.
  • Murray, S.L. and Thompson, W.F. (1980) Rapid isolation of high molecular weight plant DNA. Nucleic Acids Res. 8, 43214326.
  • Pastrana, D.V., Buck, C.B., Pang, Y.Y., Thompson, C.D., Castle, P.E., FitzGerald, P.C., Kruger Kjaer, S., Lowy, D.R. and Schiller, J.T. (2004) Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology, 321, 205216.
  • Pisani, P., Parkin, D.M., Bray, F. and Ferlay, J. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 1829.
  • Sanders, G.D. and Taira, A.V. (2003) Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg. Infect. Dis. 9, 3748.
  • Sapp, M., Fligge, C., Petzak, I., Harris, J.R. and Streeck, R.E. (1998) Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J. Virol. 72, 61866189.
  • Sasagawa, T., Tani, M., Basha, W., Rose, R.C., Tohda, H., Giga-Hama, Y., Azar, K.K., Yasuda, H., Sakai, A. and Inoue, M. (2005) A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Res. 110, 8190.
  • Schiller, J.T. and Nardelli-Haefliger, D. (2006) Chapter 17: Second generation HPV vaccines to prevent cervical cancer. Vaccine, 24 (Suppl. 3), S147S153.
  • Segui-Simarro, J.M., Testillano, P.S. and Risueno, M.C. (2003) Hsp70 and Hsp90 change their expression and subcellular localization after microspore embryogenesis induction in Brassica napus L. J. Struct. Biol. 142, 379391.
  • Staub, J.M., Garcia, B., Graves, J., Hajdukiewicz, P.T., Hunter, P., Nehra, N., Paradkar, V., Schlittler, M., Carroll, J.A., Spatola, L., Ward, D., Ye, G. and Russell, D.A. (2000) High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18, 333338.
  • Streatfield, S.J. and Howard, J.A. (2003) Plant-based vaccines. Int. J. Parasitol. 33, 479493.
  • Suzich, J.A., Ghim, S.J., Palmer-Hill, F.J., White, W.I., Tamura, J.K., Bell, J.A., Newsome, J.A., Jenson, A.B. and Schlegel, R. (1995) Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA, 92, 11 55311 557.
  • Touze, A. and Coursaget, P. (1998) In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res. 26, 13171323.
  • Tregoning, J.S., Clare, S., Bowe, F., Edwards, L., Fairweather, N., Qazi, O., Nixon, P.J., Maliga, P., Dougan, G. and Hussell, T. (2005) Protection against tetanus toxin using a plant-based vaccine. Eur. J. Immunol. 35, 13201326.
  • Varsani, A., Williamson, A.L., Rose, R.C., Jaffer, M. and Rybicki, E.P. (2003) Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch. Virol. 148, 17711786.
  • Varsani, A., Williamson, A.L., Stewart, D. and Rybicki, E.P. (2006) Transient expression of human papillomavirus type 16, L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus. Res. 120, 9196.
  • Warzecha, H., Mason, H.S., Lane, C., Tryggvesson, A., Rybicki, E., Williamson, A.L., Clements, J.D. and Rose, R.C. (2003) Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol. 77, 87028711.
  • Zhao, Q., Guo, H.H., Wang, Y., Washabaugh, M.W. and Sitrin, R.D. (2005) Visualization of discrete L1 oligomers in human papillomavirus 16 virus-like particles by gel electrophoresis with Coomassie staining. J. Virol. Methods, 127, 133140.